Navigation Links
New blood clot guidelines for pregnant women
Date:6/24/2008

s may be continued on VKA therapy because of concerns about the effectiveness of alternative anticoagulants in preventing stroke and valve thrombosis. For other women taking VKAs who become pregnant, the guidelines recommend substituting low-molecular-weight heparin (LMWH) or unfractionated heparin (UFH). The guidelines recommend two options for doing this: (1) continuing VKA but performing frequent pregnancy tests to determine when pregnancy has been achieved, followed by the substituion of LMWH or UFH as therapy; or (2) substituting VKAs with LMWH or UFH prior to conception. Although the second option eliminates the potential for fetal exposure to VKA, it provides additional challenges. LMWH and UFH are more expensive than VKAs and must be administered through a once- or twice-daily injection as opposed to a once daily oral dose of VKAs. In addition, long-term use of LMWH or UFH can be associated with osteoporosis.

"If women substitute heparin prior to pregnancy and have difficulties conceiving, they may find themselves taking the medication for a much longer timeframe than expected," said guideline coauthor Shannon Bates, MD, McMaster University and Henderson Research Centre, Hamilton, Ontario, Canada. "This is not only inconvenient but also increases treatment costs and may be associated with long-term risks for the mother."

CHILDREN

Recommendations related to childhood stroke, one of the top ten causes of death in children, and congenital heart disease have been substantially expanded since the previous guideline. Arterial ischemic stroke (AIS), usually caused by embolism or thrombosis, is difficult to diagnose in children because underlying health conditions are markedly different than those in adult stroke and up to 15% of children with AIS have no apparent risk factors. The guidelines recommend that children with AIS receive initial antithrombotic therapy until underlying causes can be determined, followed by maintenance th
'/>"/>

Contact: Jennifer Stawarz
847-498-8306
American College of Chest Physicians
Source:Eurekalert

Page: 1 2 3 4

Related medicine news :

1. Local Blood Supply at Low Levels
2. Study in Circulation provides detail on how low blood flow promotes vascular disease
3. Symptom Screening Plus a Simple Blood Test Equals a 20 Percent Jump in Early Detection of Ovarian Cancer
4. Symptoms Plus Blood Test Boost Ovarian Cancer Detection
5. Symptom screening plus a simple blood test improves early detection of ovarian cancer
6. Blood Substitute Found Safe in Large Phase III Trial
7. Low Blood Sodium Predicts Mortality in PAH Patients
8. MetLife Foundation Partners with New York Blood Center to Introduce Donor Coach to New York Boroughs
9. Cord Blood America Says Pennsylvania Joins New York and California in Informing Parents of the Advantages of Umbilical Cord Blood Storage
10. New cancer treatment targets both tumor cells and blood vessels
11. Computers as safe as medical experts in prescribing blood thinning drugs
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/5/2009)... , , SATURDAY, Dec. 5 (HealthDay News) -- ...d asthma can have bad reactions to certain holiday...ent sneezing and wheezing, according to the Americ...I). , Those who are allergic to live evergreens ma...oth live and artificial trees can trigger symptoms...
(Date:12/5/2009)Wind Turbines are popping up in the most unusual places, and to do everything from growing mushrooms, making wine to keeping prisoners in jail! , (PRWEB) December 5, 2009 -- W
(Date:12/4/2009)PEMBROKE, Bermuda, Dec. 4 Allied World Assurance,Company Holdings, Ltd (NYSE: AWH ) today announced that Scott Carmilani,President and Chief Executive Officer, and Jack Sennott, Executive Vice,Pres
(Date:12/4/2009)ANAHEIM, Calif., Dec. 4 Pamela Bowen, Chief Information Officer at Crescent Healthcare, was selected as a finalist for the "Chief Innovation Officer" Appy Award for transforming Crescent,s business w
(Date:12/4/2009)Working with mice, scientists at Johns Hopkins publishing in the December issue of Neoplasia have shown that a protein made by a gene called "Twist" may be the proverbial red flag that can accuratel
Breaking Medicine News(10 mins):Health News:Keep Asthma, Allergies at Bay for the Holidays 2Health News:Distributor Announces New Applications for Wind Turbines 2Health News:Distributor Announces New Applications for Wind Turbines 3Health News:Allied World to Present at the 2009 Goldman Sachs U.S. Financial Services Conference 2Health News:Crescent CIO '09 Dreamforce Conference Speaker and Award Finalist 2Health News:Potential new 'twist' in breast cancer detection 2Health News:Potential new 'twist' in breast cancer detection 3
... its ReNu with MoistureLoc contact lens solution b...e associated with it. Now in a new study from Uni... show that these infections were fueled and made r...call this conglomeration of cells biofilms. , On...
...monitoring of biomarkers used by, physicians to he...ses and conditions, ...nnounced today the availability of the Biophysical... usually missed in,standard annual physicals. Thro...
...p Kids Receive Care, CHICAGO, Jan. 28 In honor o...ruary, the Wm. Wrigley Jr. Company,(NYSE: WWY ) i...oss sales in,the U.S. (up to another $100,000) of ... health education,screening and treatment services...
...mical Society (ACS) News Service Weekly PressPac w...emical & Engineering News.,Please credit the indiv...the source for this information. , ALL CONTENT IS...telepathy? A bizarre new property of DNA, Journal...
...ay led to spikes in blood sugar levels , ,...suggests the caffeine in those daily cups of java ...n a small group of 10 diabetics, glucose levels ro...e consumption -- and coffee is the most common sou...
...lletin,Board: NTRZ), a world leader in stabilized ... today provided an update on its domestic,operatio...ty located in Dillon,Montana has been running at f...is fully committed to run at full capacity,through...
Other Medicine News:Health News:New study finds resistant organisms at core of soft contact lens corneal infections 2Health News:Biophysical Unveils BiophysicalCheck Health Assessment Program to Aid in Pre-Symptomatic Detection of Disease 2Health News:Biophysical Unveils BiophysicalCheck Health Assessment Program to Aid in Pre-Symptomatic Detection of Disease 3Health News:Wrigley Keeps Kids Smiling Through Donation to American Dental Association Program 2Health News:Wrigley Keeps Kids Smiling Through Donation to American Dental Association Program 3Health News:Wrigley Keeps Kids Smiling Through Donation to American Dental Association Program 4Health News:American Chemical Society's weekly PressPac -- Jan. 23, 2008 2Health News:American Chemical Society's weekly PressPac -- Jan. 23, 2008 3Health News:American Chemical Society's weekly PressPac -- Jan. 23, 2008 4Health News:American Chemical Society's weekly PressPac -- Jan. 23, 2008 5Health News:American Chemical Society's weekly PressPac -- Jan. 23, 2008 6Health News:American Chemical Society's weekly PressPac -- Jan. 23, 2008 7Health News:American Chemical Society's weekly PressPac -- Jan. 23, 2008 8Health News:American Chemical Society's weekly PressPac -- Jan. 23, 2008 9Health News:American Chemical Society's weekly PressPac -- Jan. 23, 2008 10Health News:Caffeine Could Spell Trouble for Diabetics 2Health News:NutraCea Provides Update on Domestic Operations 2Health News:NutraCea Provides Update on Domestic Operations 3
(Date:12/3/2009)SAN DIEGO, Dec. 3 BioMed Realty Trust, Inc. (NYSE: BMR ) announced today that it has entered into a new lease with Regeneron Pharmaceuticals, Inc. (Nasdaq: REGN ) for approximately 131,000 square
(Date:12/3/2009)WILMINGTON, Del., Dec. 3 ParagonRx, a Delaware-based company specializing in pharmaceutical risk management and optimal medication use, will host a free webinar on Wednesday, Dec. 9, on the FDA,s dra
(Date:12/3/2009)FORT WORTH, Texas, Dec. 3 Wound Management Technologies, Inc. (OTC Bulletin Board: WNDM), a rapidly growing provider of specialty medical products, announced today an agreement with the Health In
Breaking Medicine Technology:BioMed Realty Trust Signs New Lease With Regeneron Pharmaceuticals for 131,000 Square Feet at Landmark 2BioMed Realty Trust Signs New Lease With Regeneron Pharmaceuticals for 131,000 Square Feet at Landmark 3Wound Management Technologies, Inc. Signs Agreement with Major Sales Representative Organization for Increased Marketing of CellerateRx(R); Third Quarter Sales Up 2Wound Management Technologies, Inc. Signs Agreement with Major Sales Representative Organization for Increased Marketing of CellerateRx(R); Third Quarter Sales Up 3Centrix Pharmaceutical Announces Clofera 28TM 29 a Unique Antitussive and Nasal Decongestant for the Temporary Relief of Cough and Nasal Congestion 54520 1Centrix Pharmaceutical Announces Clofera 28TM 29 a Unique Antitussive and Nasal Decongestant for the Temporary Relief of Cough and Nasal Congestion 54520 2CordLife Makes Headway into China 54519 1CordLife Makes Headway into China 54519 2CordLife Makes Headway into China 54519 3CordLife Makes Headway into China 54519 4CordLife Makes Headway into China 54519 5Oxygen Biotherapeutics Inc to Begin Oxycyte 28R 29 Phase II Clinical Trials in Switzerland 54517 1Oxygen Biotherapeutics Inc to Begin Oxycyte 28R 29 Phase II Clinical Trials in Switzerland 54517 2Oxygen Biotherapeutics Inc to Begin Oxycyte 28R 29 Phase II Clinical Trials in Switzerland 54517 3
...ration Oxazolidinone Enrolls in Four Months , , ... announced the completion of enrollment in its ran...ng the oral dosage form of torezolid (also known a...in structure infections (cSSSI). The trial, which...States, examined the efficacy and safety of three ...
.... 23 Today the FDA announced,approval for the fir...Cells,but Adult Stem Cell scientist Christian Drap...story; Adult Stem Cells have greater potential wit...xciting step forward toward freeing science,from t...t commentary we,re,seeing surrounding the FDA,s ac...
Other Medicine Technology:Trius Completes Enrollment in Phase 2 Clinical Trial Evaluating Torezolid (TR-701) in Patients With Complicated Skin and Skin Structure Infections 2FDA Stem Cell Approval Breakthrough Laudable 2
...e HF-compatible V series from Pentax, the standard...ed., ,The HF-compatible series of fibre bronchosc...d FB-15V models along with the very slim FB-10V an...lity thanks mainly to the higher resolution and wi...
BRO-YP2 Pediatric Bronchoscope
OES BF-40 Bronchoscope
...ofiberscopes with electrosurgical capability, has ...nd for expanded bronchoscopic diagnostic and treat...l section and ergonomic design to facilitate incre...eld of view, a smaller insertion tube and distal e...
Medicine Products: